Article
Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients.
Kidney international - 1 May 1995
Pol S, Thiers V, Carnot F, Zins B, Romeo R, Berthelot P, Bréchot C
Abstract excerpt
A high frequency (25%) of anti-hepatitis C virus (HCV) antibodies is observed in French hemodialyzed patients; this is associated with detectable viremia in 85% and results in chronic hepatitis in more than 90%. We conducted a pilot study to examine the tolerance and efficacy of alpha-2b Interferon therapy upon HCV infection in hemodialyzed patients. Nineteen anti-HCV positive hemodialyzed patients were given a...
Topics
- Base Sequence
- DNA, Viral
- Female
- Follow-Up Studies
- Genotype
- Hepacivirus
- Hepatitis C
- Humans
- Interferon alpha-2
- Interferon-alpha
- Male
- Middle Aged